Complete EWTX Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
EWTX Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-44.81
-403.9%
Peer Median: 29.2x
EV/EBITDA
$0.00
-100.0%
Peer Median: 10.6x
P/S Ratio
$0.00
-100.0%
Peer Median: 2.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for EWTX's business model and current situation.
Multiple Comparison
Multiple | EWTX Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -9.6x | 29.2x | 37.6x | -132.9% | Undervalued |
EV/EBITDA | Infinityx | 10.6x | 19.8x | Infinity% | Overvalued |
P/S Ratio | Infinityx | 2.7x | 5.3x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$2.02B | 13.5x | 7.8x | 2.7x | |
$1.81B | 29.2x | 10.6x | 2.7x | |
$1.82B | 0.0x | 0.0x | 7.8x | |
$1.55B | 0.0x | 0.0x | 0.0x | |
$1.52B | 0.0x | 0.0x | 107.7x | |
$1.30B | 74.5x | 28.4x | 1.9x | |
$1.21B | 9.0x | 7.1x | 1.7x | |
$722.17B | 61.8x | 45.1x | 14.7x |